首页> 外文OA文献 >Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from seasonal Allergic Rhinitis with symptoms aggravated in presence of pollutants

【2h】

Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from seasonal Allergic Rhinitis with symptoms aggravated in presence of pollutants

机译：第3阶段，单中心，顺序和平行组，双盲，随机研究评估FexofeNadine盐酸盐的疗效和安全性180 mg（Allegra®/Telfast®）与安慰剂在患有季节性过敏性鼻炎的受试者中，存在于存在的症状污染物

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Anne K. Ellis; Margarita Murrieta-Aguttes; Sandy Furey; Christopher Carlsten;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Double-blind, placebo-controlled study comparing the efficacy and safety of fexofenadine hydrochloride (120 and 180 mg once daily) and cetirizine in seasonal allergic rhinitis. [J] . Howarth PH, Stern MA, Roi L, The Journal of Allergy and Clinical Immunology . 1999,第5期

机译：一项双盲，安慰剂对照研究，比较了盐酸非索非那定（每日一次120和180 mg）和西替利嗪在季节性变应性鼻炎中的疗效和安全性。
2. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled [J] . Berkowitz RB, McCafferty F, Lutz C, Clinical therapeutics . 2006,第10期

机译：盐酸非索非那定60 mg /盐酸伪麻黄碱120 mg在12岁中度至重度季节性过敏性鼻炎患者中的起效作用：两种单剂量，随机，双盲，安慰剂对照的汇总分析
3. Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis [J] . Kimihiro Okubo, Eiji Uchida, Takaaki Terahara, Allergology international: official journal of the Japanese Society of Allergology . 2018,第3期

机译：Emedastine贴片（一种用于过敏性鼻炎的新型透皮给药系统）的功效和安全性：季节性季节性鼻炎患者的III期，多中心，随机，双盲，安慰剂对照，平行组比较研究
4. Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized double-blind placebo- and active-referenced studies [O] . Paul Ratner, Charles P. Andrews, Frank C. Hampel, 2017

机译：骨化剂在季节性变应性鼻炎中的功效和安全性：第2期和第3期随机双盲安慰剂和活性对照研究的结果
5. Efficacy and Safety of Fexofenadine Hydrochloride for Pediatric Perennial Allergic Rhinitis in a Phase III, Randomized, Double-blind, Multi-center Comparative Study [O] . Kotaro Baba 2007

机译：盐酸盐酸盐酸盐酸盐的疗效和安全性常年过敏性鼻炎在III期，随机，双盲，多中心比较研究中

Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from seasonal Allergic Rhinitis with symptoms aggravated in presence of pollutants

著录项

引文网络

相似文献

相关主题

期刊订阅